Proseek Bio
Scalable precision for ovarian cancer detection
Proseek Bio is commercialising simple multi-biomarker blood tests to reduce the reliance on surgical ovarian cancer diagnosis thus enabling earlier detection and better outcomes.
The advanced diagnostic products are designed for high scalability into global commercial laboratories with existing clinical mass spectrometers.
Team: Leo Bolero, Michelle Hill
Leo Bolero - Cofounder, Michelle Hill - Cofounder, Idris Mohd Najib - Product Development Lead